Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment
Autonomix Medical (NASDAQ: AMIX) has published a new CEO Corner segment on its website. The segment features CEO Brad Hauser's reflections on the company's progress throughout the past year and provides insights into future plans. Autonomix is a medical device company that focuses on developing innovative technologies for diagnosing and treating diseases of the nervous system.
Autonomix Medical (NASDAQ: AMIX) ha pubblicato un nuovo segmento CEO Corner sul suo sito web. Il segmento presenta le riflessioni del CEO Brad Hauser sui progressi dell'azienda nell'ultimo anno e offre spunti sui piani futuri. Autonomix è un'azienda di dispositivi medici che si concentra sullo sviluppo di tecnologie innovative per la diagnostica e il trattamento delle malattie del sistema nervoso.
Autonomix Medical (NASDAQ: AMIX) ha publicado un nuevo segmento de CEO Corner en su sitio web. El segmento presenta las reflexiones del CEO Brad Hauser sobre el progreso de la empresa durante el último año y ofrece perspectivas sobre los planes futuros. Autonomix es una empresa de dispositivos médicos que se especializa en desarrollar tecnologías innovadoras para el diagnóstico y el tratamiento de enfermedades del sistema nervioso.
Autonomix Medical (NASDAQ: AMIX)가 자사 웹사이트에 새로운 CEO Corner 세그먼트를 발표했습니다. 이 세그먼트는 CEO 브래드 하우저의 지난 한 해 동안 회사의 발전에 대한 반성과 향후 계획에 대한 통찰을 제공합니다. Autonomix는 신경계 질환의 진단 및 치료를 위한 혁신적인 기술 개발에 중점을 둔 의료 기기 회사입니다.
Autonomix Medical (NASDAQ: AMIX) a publié un nouveau segment CEO Corner sur son site web. Ce segment présente les réflexions du PDG Brad Hauser sur les progrès de l'entreprise au cours de l'année écoulée et offre des aperçus sur les projets futurs. Autonomix est une entreprise de dispositifs médicaux qui se concentre sur le développement de technologies innovantes pour le diagnostic et le traitement des maladies du système nerveux.
Autonomix Medical (NASDAQ: AMIX) hat ein neues CEO Corner-Segment auf seiner Website veröffentlicht. Das Segment präsentiert die Überlegungen von CEO Brad Hauser zum Fortschritt des Unternehmens im vergangenen Jahr und bietet Einblicke in zukünftige Pläne. Autonomix ist ein Medizintechnikunternehmen, das sich auf die Entwicklung innovativer Technologien zur Diagnose und Behandlung von Erkrankungen des Nervensystems konzentriert.
- None.
- None.
THE WOODLANDS, TX, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the next CEO Corner segment has been published on the Company’s website. For the CEO Corner segment, Brad Hauser, CEO of Autonomix, reflected on the Company’s progress made over the last year and shared insight into the year ahead.
The CEO Corner segment is now available here.
About Autonomix Medical, Inc.
Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.
We are initially developing this technology for the treatment of pain, with initial trials focused on pancreatic cancer, a condition that causes debilitating pain and is without a reliable solution. Our technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Our technology is investigational and has not yet been cleared for marketing in the United States.
For more information, visit autonomix.com and connect with the Company on X, LinkedIn, Instagram and Facebook.
Investor and Media Contact
JTC Team, LLC
Jenene Thomas
908.824.0775
autonomix@jtcir.com
FAQ
What did Autonomix Medical (AMIX) announce in their December 23, 2024 press release?
What is the main focus of Autonomix Medical's (AMIX) business?
What topics does the new AMIX CEO Corner segment cover?
Who is featured in Autonomix Medical's (AMIX) latest CEO Corner segment?
